Health TrialsbyHealthPanel

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

ConditionsMyomaSurgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorThe University of Texas Health Science Center, Houston

About this trial

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/>5cm or

Patients undergoing minimally invasive Myomectomy with =/> 5 fibroids

Disqualifiers

Pregnancy,

Age <18yo,

Patients undergoing concomitant surgery such as endometriosis surgery,

Suspected malignancy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Temporary clamping of uterine and ovarian vessels

    Other intervention

    Surgeon will temporarily clamp uterine and ovarian vessels.

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Temporary vessel clampsExperimental treatment 1 intervention
Group B: No Temporary vessel clampsNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Estimated blood loss

Estimated blood loss during the surgery between groups, calculated by suction prior to irrigation.

Time frame
Intraoperative (during surgery, which is < 24 hours)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The University of Texas Health Science Center, Houston

Lead sponsor

Source ClinicalTrials.gov
Apply now